Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-03-16 @ 5:01 PM
Study NCT ID:
NCT05638451
Status:
UNKNOWN
Last Update Posted:
2024-06-05
First Post:
2022-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
Sponsor:
Organization: